Tag: GlobalData
Esperion Therapeutics’ ‘bempedoic acid’ shows potential to reduce cardiac illnesses, reveals GlobalData
Esperion Therapeutics’ non-statin therapy “bempedoic acid” has shown modest results in reducing the risk of major cardiovascular events in statin-intolerant patients in the cholesterol...
Drug pricing, reimbursement issues to remain key barriers to pharmaceutical sector growth: GlobalData
GlobalData has identified drug pricing and reimbursement-related concerns as the key impediment to the pharmaceutical industry’s growth in 2022.
These barriers could even force pharmaceutical...
Ethnic disparity in clinical trials hampers health strategies, says GlobalData
There is a growing concern of ethnic disparity in clinical trials, London-headquartered data analytics and consulting firm, GlobalData says, quoting recent data.
The data presented...
What will be pharma industry’s main concern in 2020? GlobalData survey picks drug pricing and reimbursement constraints
Drug pricing and reimbursement continue to be the leading concern for the pharmaceutical industry in 2020, according to GlobalData.
In its annual outlook report, titled...
COPD cases in UK to rise but not as much as elsewhere in Europe in 2020s
A leading international data analytics firm predicts a 13.3 per cent increase in the total prevalent cases of chronic obstructive pulmonary disease (COPD) over...